PEERS Multicenter Osseospeed TM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study (GAST)

November 15, 2012 updated by: Prof. Dr. Dr. Wilfried Wagner, Johannes Gutenberg University Mainz

PEERS Multicenter OsseoSpeedTM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study An Open, Prospective Observational Study to Evaluate Implant Stability, Marginal Bone and Soft Tissue Maintenance of the Astra Tech Dental Implant System: OsseoSpeedTM TX Profile Implant in Patients With Tooth Loss in the Aesthetic Zone or the Posterior Atrophied Mandible

The open, prospective, non-controlled observational study is designed to provide information on the short-, medium- and long-term clinical performance of the Astra Tech OsseospeedTM implant surface in combination with a special implant design. The study will provide information on implant survival and soft tissue and bone maintenance as clinical performance of the OsseoSpeedTM TX Profile Implant in the aesthetic zone or the posterior mandible with socket like atrophy.

Study Overview

Detailed Description

Within the new OsseoSpeedTM TX Profile Implant from Astra Tech a special surface modification treated with diluted hydrofluoric acid is combined with an inclined implant-abutment interface to support soft tissue and marginal bone maintenance in the aesthetic zone or the socket like atrophy in the mandible. Pre-clinical studies of the OsseospeedTM modification support improvement in osseointegration. Both aspects are of special clinical interest in critical situations e.g. reduced bone quantity and quality or in case of socket atrophy with loss of the papillae. The outcome variables of interest are implant survival and the marginal bone and soft tissue response for clinical evaluation of the OsseoSpeedTM TX Profile Implant from Astra Tech. In contrast to the original treatment protocol with a healing period of 3 and 6 months for maxilla and mandible, respectively, the healing period is reduced to 3 months following the recent literature with equal clinical results. Within the present study implants will heal in a transgingival mode and loaded after a healing period of 3 months. For special indications in the aesthetic zone the implants may optionally be loaded following an early loading protocol, which comprehend temporary loading within 48h after implant insertion. Overall implant survival rates are high. However, for implants placed immediately after tooth extraction in the esthetic zone or in the socket like atrophied mandible survival rates are lower. The special physiology of bone resorption in the aesthetic zone exhibit high requirements for soft tissue and bone maintenance for good clinical long term results. Differences in pattern of marginal bone response have been described for different implant systems. The extend of bone loss as also the pattern of remodeling as reaction to OsseospeedTM surface and the special shape of the OsseoSpeedTM TX Profile Implant will be investigated within the present study.

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, D-10117
        • Recruiting
        • MSc. E. Trilck
      • Berlin, Germany, D-10969
        • Recruiting
        • Dr.Dr. U. Schwarzott
      • Berlin, Germany, D-14199
        • Recruiting
        • Dr. M. Loeck
      • Bielefeld, Germany, D-33602
        • Recruiting
        • Dr. G. Körner
      • Braunschweig, Germany, D-38126
        • Recruiting
        • PD.Dr.Dr. E. Keese
      • Dortmund, Germany, D-44145
        • Recruiting
        • Klinik für MKG Chirurgie Dortmund
        • Contact:
          • Stefan Haßfeld, MD, DMD, PHD
      • Essen, Germany, D-45259
        • Recruiting
        • Dr.Dr. V. Michalczik
      • Euskirchen, Germany, D-53879
        • Recruiting
        • Dr. M.Sc. Gau
      • Forchheim, Germany, D-91301
        • Recruiting
        • Dr. M. Schlee
      • Freiberg, Germany, D-09599
        • Recruiting
        • Dr. Borrmann
      • Gernsbach, Germany, D-76593
        • Recruiting
        • Dr. H. Steveling
      • Hamburg, Germany, D-20095
        • Recruiting
        • Dr. Dr. St. Kahnel
      • Hamburg, Germany, Hamburg
        • Recruiting
        • Dr. U. Konter
      • Hannover, Germany, D-30169
        • Recruiting
        • K. Bothe
      • Hannover, Germany, D-30625
        • Recruiting
        • Klinik für MKG Chirurgie MH Hannover
        • Contact:
          • Nils-Claudius Gellrich, MD, DMD, PHD
        • Contact:
          • Jan-Thomas Krause
      • Heidelberg, Germany, 69120
        • Recruiting
        • Dr. Ch. Mertens
      • Leipzig, Germany, D-04177
        • Recruiting
        • Dr. W. Knöfler
      • Lindau, Germany, 88131
        • Recruiting
        • Dr. R. Noelken
        • Contact:
          • Robert Noelken, DMD
        • Contact:
          • Bettina Anna Neffe
      • Lorsch, Germany, D-64653
        • Recruiting
        • Dr.Dr. R. Wörtche
      • Mannheim, Germany, D-68183
        • Recruiting
        • Dr. Dr. Barth
        • Contact:
          • Tilo J Barth, MD, DMD
      • Melsungen, Germany, D-34212
        • Recruiting
        • Dr. P. Rauch
      • Nagold, Germany, 72202
        • Recruiting
        • Dr. MMsc Dirlewanger
      • Oldenburg, Germany, 26122
        • Recruiting
        • Prof. Dr. H. Visser
      • Rückersdorf, Germany, D-90607
        • Recruiting
        • Dr.Dr. M. Kestel
      • Saalfeld, Germany, D-07318
        • Recruiting
        • Dr. J. U. Wiegner
      • Stein, Germany, D-90547
        • Recruiting
        • Dr. M. Riedl
      • Wiesbaden, Germany, 65183
        • Recruiting
        • Tagesklinik für Kiefer- und Plastische Gesichtschirurgie
        • Contact:
          • Rainer SR Buch, MD, DMD
        • Contact:
          • Christian Küttner, MD, DMD
    • Rheinland-Pfalz
      • Mainz, Rheinland-Pfalz, Germany, 55131
        • Not yet recruiting
        • Department of Oral and Maxillofacial Surgery, University Mainz, Medical Center
        • Contact:
        • Contact:
        • Principal Investigator:
          • Wilfried Wagner, MD, DMD, PHD
        • Sub-Investigator:
          • Maximilian Moergel, MD, DMD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with tooth loss in the aesthetic zone or in the distal mandible with socket like atrophy. The antagonists should be natural teeth or a fixed prosthesis.

Description

Inclusion Criteria:

  • loss of tooth aesthetic zone (a maximum of 4 implants)
  • loss of tooth at the distal mandible (distal canine) (a maximum of 4 implants)
  • presence of inclined alveolar ridge profile
  • antagonists are natural teeth or fixed prosthesis

Exclusion Criteria:

  • < 18 years
  • Tumour or irradiation
  • bisphosphonate or cortisone intake
  • Diabetes mellitus
  • Mental illness or disorder with affection of compliance
  • Consumption of > 20 cigarettes/day
  • Bruxism
  • Acute Mucosal infection or illness (e.g. acute Parodontitis, Pemphigus, Lichen)
  • Relation of Crown to Implant ratio of > 1
  • No clinical primary stability of the implant after insertion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Distal region
Patients with loss of tooth in the premolar and molar region of the atrophied mandible
aesthetic zone
Patients with loss of tooth within the aesthetic zone (canine to canine)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant survival
Time Frame: after 24 months
How many implants are in situ after an observational period of 24 months (2 years). Data presentation will be a Kaplan Meier Estimate.
after 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marginal bone adaption
Time Frame: after 24 months
Marginal bone adaptation will be assessed clinically as probing depth on the lingual aspect of insertion. In addition marginal bone adaption will be followed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant on intraoral radiographs with paralleling technique. Periapical radiographs will be taken pre- and postoperatively at 24 months follow-up visit. A change in marginal bone will be recorded as positive or negative shift compared to the baseline (preoperatively measured bone height).
after 24 months
Pinc aesthetic parameter
Time Frame: after 24 months
Pinc aesthetic score evaluation as previously described by Fürhauser and measurement of width of keratinized mucosa and clinical crone length. Data evaluation will be a negative or positive shift compared to the preoperatively evaluated data.
after 24 months
periodontal parameter
Time Frame: after 24 months
Clinical evaluation of of probing depth in mm (mesial, distal, oral and vestibular), bleeding on probing and Plaque Index as described by Sillness and Löe. Data evaluation will be a negative or positive shift compared to the preoperatively evaluated data.
after 24 months
Detection and description of implant related complications and other adverse and serious adverse events
Time Frame: over the study period (24 months)

Complications are characterized by any failure (mechanical or other) of the implant and/or the prosthetic restoration, as well as the treatment of such failures and will be recorded. The following complications must be reported to the Principal Investigator within 4 working days:

  • Failed osseointegration
  • Lost osseointegration
  • Fixture fracture Adverse events and serious adverse events detection and reporting following GCP-ICH
over the study period (24 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Wilfried Wagner, MD, DMD, PHD, Department of Oral and Maxillofacial Surgery, University Mainz, Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Anticipated)

July 1, 2014

Study Completion (Anticipated)

July 1, 2014

Study Registration Dates

First Submitted

June 7, 2011

First Submitted That Met QC Criteria

July 21, 2011

First Posted (Estimate)

July 22, 2011

Study Record Updates

Last Update Posted (Estimate)

November 16, 2012

Last Update Submitted That Met QC Criteria

November 15, 2012

Last Verified

November 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GAST

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inclined Atrophy of the Distal Mandible

Subscribe